Threshold Pharmaceuticals (THLD) says it will be providing additional details next week from a...

|About: Threshold Pharmaceuticals, ... (THLD)|By:, SA News Editor

Threshold Pharmaceuticals (THLD) says it will be providing additional details next week from a Phase IIb clinical trial for its TH-302 pancreatic cancer drug candidate during the American Association for Cancer Research annual meeting in Chicago. Shares +1.4% AH.